The last time I spoke about Monte Rosa Therapeutics (NASDAQ:GLUE) it was with respect to a Seeking Alpha article I wrote titled "Monte Rosa: Novartis Deal Bolsters MGD Platform With Flush Of Cash." ...
Data will be presented during Poster Session A on Sunday, November 12, 2023 from 9:00-11:00 am PT BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a ...
CDK2 molecular glue degrader MRT-51443 shows enhanced tumor regression and delayed resistance in breast cancer models, surpassing standard treatments. Details regarding the clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback